<DOC>
	<DOCNO>NCT03006809</DOCNO>
	<brief_summary>This prospective unblinded , randomized trial use Fecal Microbiota Transplantation ( FMT ) treatment Ulcerative Colitis ( UC ) , combination without antibiotic pretreatment .</brief_summary>
	<brief_title>Optimal Fecal Microbiota Transplant Dosing Mild Moderate Ulcerative Colitis</brief_title>
	<detailed_description>This prospective open-label , randomize trial use Fecal Microbiota Transplantation ( FMT ) treatment Ulcerative Colitis ( UC ) , combination without antibiotic pretreatment . This trial involve 11 study visit UCSF San Francisco , CA . The route administration via colonoscopy subject maintenance therapy administer orally ( i.e . use encapsulated FMT ) half subject per rectum enema half subject . Additionally , utility pretreatment antibiotic assess .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Patients history mild moderate Ulcerative Colitis confirm endoscopy pathology . Total Mayo score 49 , endoscopic subscore ≥1 ; patient endoscopic evaluation within one year enrollment flexible sigmoidoscopy evaluation . Age 18 64 deem otherwise healthy discretion investigator . Concurrent therapy mesalamine ( stable x 4 week ) , immunomodulators ( stable x 3 month ) , biologic agent ( stable x 3 month ) allow continue study . If patient prednisone , dose must ≤ 10mg/day time treatment wean 2.5mg/week study period . Severe refractory UC define Mayo score ≥10 , endoscopic disease activity score 3 Untreated enteric infection ( positive stool test following : Clostridium difficile , Salmonella , Shigella , Yersinia , Campylobacter , enteropathogenic E. coli enteric infection discretion investigator . History colectomy Disease limit distal proctitis Patients take probiotic within 6 week plan FMT therapy . Severe immunodeficiency , inherit acquire ( e.g . HIV , chemotherapy radiation therapy ) Patients follow laboratory abnormality : absolute neutrophil count ( ANC ) &lt; 1000 / µl , platelets &lt; 50 x 10^9 /L , , hemoglobin &lt; 6.5 g/dL.. History anaphylaxis ( severe allergic reaction ) food allergen ( e.g . tree nut , shellfish ) Dysphagia ( oropharyngeal , esophageal , functional , neuromuscular ) History recurrent aspiration episode Documented severe gastroparesis Active intestinal obstruction Patients renal insufficiency ( GFR &lt; 50ml/min ) Allergy follow generally regard safe ingredient ( GRAS ) : glycerol , acid resistant HPMC , gellan gum , cocoa butter , titanium dioxide Adverse event attributable previous FMT Allergy/intolerance proton pump inhibitor therapy Allergy/intolerance vancomycin , metronidazole , neomycin . Nonsteroidal inflammatory medication ( NSAIDs ) longterm treatment , define use least 4 day week month . Cholestyramine use Any condition investigator think FMT treatment may pose health risk ( e.g . severely immunocompromised ) Simultaneous participation another interventional clinical trial Patients pregnant , breast feeding planning pregnancy study trial period . During trial period one week trial end : Nonuse appropriate contraceptive female childbearing potential ( e.g . condom , intrauterine device ( IUD ) , hormonal contraception , mean consider adequate responsible investigator ) males childfathering potential ( condom , mean consider adequate responsible investigator treatment ) wellfounded doubt patient 's cooperation Patients significant medical condition could confound interfere evaluation safety , tolerability prevent compliance study protocol discretion investigator Life expectancy &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>FMT</keyword>
	<keyword>fecal transplant</keyword>
</DOC>